Having now read through the contents of the transcript and Q&A transcript twice, it appears quite promising for Mesoblast particularly now that efficacy is not an issue for the FDA. main issue is funding and the timing of funding, can be overcome by partnering up quicker rather than later.
banter and General Discussion, page-7576
-
- There are more pages in this discussion • 2,981 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
-0.008(0.74%) |
Mkt cap ! $1.158B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.00 | $1.600M | 1.586M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 105363 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 80343 | 27 |
View Market Depth
| Last trade - 15.02pm 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |